-
-
-
-
-
-
-
Rigel reports Q4 revenue of $69.8 million, projects 2026 growth
-
-
-
-
-
-
-
Rigel Pharmaceuticals (RIGL) PT Raised to $23 at Jefferies
-
-
-
-
-
-
-
NeuroPace Inc (NPCE) PT Raised to $20 at Cantor Fitzgerald
-
-
-
-
-
-
-
Rigel Pharma (RIGL) Announces R289 Granted FDA Fast Track Designation
-
-
-
-
-
-
-
Rigel Pharmaceuticals (RIGL) PT Raised to $57 at H.C. Wainwright
-
-
-
-
413,534 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

